Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-04-15

Clinical Trial Update: Irbesartan Versus Placebo in Combination With Ramipril for Treatment of Albuminuria [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing irbesartan to placebo in addition to ramipril for the treatment of albuminuria has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Irbesartan (irbesartan)
  • Ramipril (ramipril)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Albuminuria | Phase 4 | Status: COMPLETED